GEODE CAPITAL MANAGEMENT, LLC - INHIBIKASE THERAPEUTICS INC ownership

INHIBIKASE THERAPEUTICS INC's ticker is IKT and the CUSIP is 45719W106. A total of 23 filers reported holding INHIBIKASE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of INHIBIKASE THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$58,557
+132984.1%
89,0480.0%0.00%
Q4 2022$44
-99.9%
89,048
-0.2%
0.00%
Q3 2022$81,000
+22.7%
89,2260.0%0.00%
Q2 2022$66,000
-46.8%
89,226
+6.0%
0.00%
Q1 2022$124,000
+6.9%
84,209
+6.4%
0.00%
Q4 2021$116,000
+136.7%
79,128
+206.3%
0.00%
Q3 2021$49,00025,8330.00%
Other shareholders
INHIBIKASE THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
ACT CAPITAL MANAGEMENT, LLC 937,500$696,0000.97%
HAMILTON LANE ADVISORS LLC 165,635$123,0000.05%
Redmond Asset Management, LLC 122,682$91,0000.03%
Retirement Planning Co of New England, Inc. 64,606$47,0000.03%
Antara Capital LP 403,000$299,0000.01%
ZEKE CAPITAL ADVISORS, LLC 93,800$70,0000.01%
Koshinski Asset Management, Inc. 65,377$49,0000.01%
K.J. Harrison & Partners Inc 18,300$14,0000.00%
Warberg Asset Management LLC 14,493$11,0000.00%
Shay Capital LLC 10,708$8,0000.00%
View complete list of INHIBIKASE THERAPEUTICS INC shareholders